Claims; Litigation. There is no claim, litigation or condemnation proceeding pending, or, to the knowledge of the Borrower, threatened, against the Property or Borrower, which would be likely to have a material adverse affect on the Property or Borrower's ability to perform its obligations in the connection with the Loan.
Claims; Litigation. The Company: (i) is not (and since December 31, 1999 has not been) engaged in, a party to, subject to or threatened with any claim, controversy, legal or equitable action or other proceeding (whether as plaintiff, defendant or otherwise and regardless of the forum or the nature of the opposing party); (ii) is not (and since December 31, 1999 has not been) a party to or subject to any judgment, order or decree against it or any of its assets; and (iii) there has been no reservation of rights by any insurance carrier, and to the Stockholders' knowledge, no such reservation is threatened, concerning the coverage of the Company with respect to any such matter.
Claims; Litigation. The County shall have the right to refuse or return any Contract Agency inmate that files a claim or lawsuit against the County in the interest of safety and security and preserving the rights of all affected parties.
Claims; Litigation. Except as described in Schedule 4.5 attached hereto, there is no action, claim, suit, arbitration, or other legal or administrative proceeding, pending, or, to the knowledge of Solvay or its Affiliates, threatened against, Solvay or its Affiliates pertaining to the API or either or both Products or the development, use, sale, import, marketing, promotion, distribution or manufacture of any thereof, the NDAs or the Elan Agreement and, to Solvay’s or its Affiliates’ knowledge, no governmental investigation pertaining to any of the foregoing is pending or threatened. There is no judgment, decree, injunction, rule or order of any court, governmental department, commission, agency, instrumentality or arbitrator or other similar ruling outstanding against Solvay or its Affiliates relating to the API or the Products or the development, use, sale, import, marketing, promotion, distribution or manufacture thereof, the NDAs or the Elan Agreement.
Claims; Litigation. The Company and the Subsidiaries has not been served with any summons or notice to arbitrate. There is, to Sellers Knowledge, no action or other proceedings pending or threatened by the Company or the Subsidiaries against any other person or entity regarding any Material Contracts.
Claims; Litigation. Borrower will inform Lender, promptly after receipt by Borrower of notice of any material threatened or potential adverse claim, dispute, litigation and governmental investigation or citation against Borrower that, if adversely determined, is reasonably likely to result in a Material Adverse Effect.
Claims; Litigation. There is no action or proceeding pending and, to County’s knowledge, County has received no written notice of any threatened actions or proceedings against County or the Property, including condemnation proceedings, which challenges or impairs County’s ability to execute or perform its obligations under this Agreement.
Claims; Litigation. No claims, litigation or other proceedings are pending or, to Buyer’s knowledge, threatened against Buyer that could adversely affect the consummation of the transactions contemplated by this Agreement.
Claims; Litigation. Compliance with Laws; Approvals Schedule 5.6........................ - Agreements; Contracts; Warranties Schedule 5.7........................ - Proprietary Rights Schedule 5.8........................ - Employees; Employee Benefits Schedule 5.9........................ - Insurance Schedule 5.11....................... - Undisclosed Liabilities Schedule 5.12(d).................... - Audited Tax Returns Schedule 5.12(f).................... - Understatement Penalties Schedule 5.13....................... - Absence of Changes or Events Schedule 5.14....................... - Environmental & Occupational Matters Schedule 5.15....................... - Subsidiaries Schedule 5.16....................... - Capitalization Schedule 5.17....................... - Bank Accounts Schedule 5.18....................... - Guarantees Schedule 5.19....................... - Related Parties Schedule 5.20....................... - Brokers (GET) Schedule 5.21....................... - Year 2000 Compliance Schedule 7.4........................ - Brokers (Jabil) Schedule 8.7........................ -
Claims; Litigation. Dura is not aware of any claim, suit, action, arbitration, governmental investigation or other proceeding, nor any order, decree or judgment pending or in effect, or threatened by, against or relating to the CCA/Rondec Products, the CCA Trademarks, the Rondec Patent or the trademark Rondec which if determined adversely would have an adverse effect on DJ Pharma's rights to manufacture or have manufactured, market, distribute, offer for sale and sell the CCA/Rondec Products.
